Boise Paper_Color_PCA.png
How to Select Office Paper that Impacts Productivity, Profitability in 2020
14 janv. 2020 09h00 HE | Boise Paper Holdings LLC
CHICAGO, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Office paper may seem like a small expense to many people, but business owners know it can directly impact their productivity and profitability. As small...
download-2.png
Les résultats financiers d'Emerald Health Therapeutics au deuxième trimestre 2019 indiquent un doublement des ventes pour le deuxième trimestre consécutif
30 août 2019 05h10 HE | Emerald Health Therapeutics Inc.
VANCOUVER, Colombie-Britannique, 30 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a communiqué aujourd'hui ses résultats financiers...
download-2.png
Emerald Health Therapeutics Reports Second Quarter 2019 Financial Results; Sales Double Second Quarter in a Row
29 août 2019 07h00 HE | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended June 30,...
download-2.png
La coentreprise Pure Sunfarms d'Emerald Health Therapeutics a réalisé un chiffre d'affaires de 32 millions $ au deuxième trimestre, une marge d'EBITDA de 78 %, un coût de production global de 0,65 $/g et un troisième trimestre de rentabilité consécutif
13 août 2019 11h32 HE | Emerald Health Therapeutics Inc.
VICTORIA, Colombie-Britannique, 13 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH, OTCQX: EMHTF) a publié des résultats financiers préliminaires non...
download-2.png
Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
13 août 2019 00h19 HE | Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has provided preliminary, unaudited financial results for the...
download-2.png
Emerald Health Therapeutics Appoints Chief Executive Officer
30 juil. 2019 07h00 HE | Emerald Health Therapeutics Inc.
Riaz Bandali has driven innovation, sales, and profitability in a number of global life science companies Emerald also adds Chief Commercial Officer VICTORIA, British Columbia, July 30, 2019 ...
CapStar Logo.jpg
CapStar Reports Fully Diluted EPS of $0.25 and Fully Diluted Operating EPS of $0.28 for 1Q2019
24 avr. 2019 16h20 HE | CapStar Financial Holdings, Inc.
NASHVILLE, Tenn., April 24, 2019 (GLOBE NEWSWIRE) -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported net income of $4.78 million, or $0.25 per share on a fully diluted basis, for...
PwC Logo.jpg
Traditional cost-cutting measures aren’t enough to solve current profitability crisis in Financial Services industry
05 févr. 2019 09h58 HE | PwC
NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- In a new report titled: The productivity agenda – moving beyond cost reduction in financial services, PwC sets out the important challenges and...
CapStar Logo.jpg
CapStar Reports Fully Diluted EPS of ($0.04) and Fully Diluted Operating EPS of $0.33 for 4Q 2018
24 janv. 2019 19h09 HE | CapStar Financial Holdings, Inc.
NASHVILLE, Tenn., Jan. 24, 2019 (GLOBE NEWSWIRE) -- CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) reported a net loss of ($0.7) million, or ($0.04) per share on a fully diluted basis,...
BCG_Logo_compact_RGB.jpg
Asset Managers’ Global Growth Surge Sets Stage for Digital Competition
19 juil. 2018 12h00 HE | BCG
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- A surge in global growth by the asset management industry, occurring as advanced digital and analytics are finally going mainstream, has positioned firms...